AlzeCure Pharma AB (publ) (STO:ALZCUR)
6.28
-0.12 (-1.88%)
Nov 2, 2026, 3:13 PM CET
AlzeCure Pharma AB Employees
AlzeCure Pharma AB had 10 employees as of June 30, 2026. The number of employees decreased by 1 or 9.09% compared to the same quarter last year. That makes AlzeCure Pharma AB the 40,365th largest employer in the world and 642nd in Sweden.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
9.73M SEK
Profits / Employee
3.07M SEK
Market Cap
866.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 10 | -1 | -9.09% |
| Mar 31, 2026 | 10 | -1 | -9.09% |
| Dec 31, 2025 | 10 | -1 | -9.09% |
| Sep 30, 2025 | 11 | 0 | - |
| Jun 30, 2025 | 11 | 0 | - |
| Mar 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | 0 | - |
| Sep 30, 2024 | 11 | 0 | - |
| Jun 30, 2024 | 11 | 0 | - |
| Mar 31, 2024 | 11 | -1 | -8.33% |
| Dec 31, 2023 | 11 | -2 | -15.38% |
| Sep 30, 2023 | 11 | -3 | -21.43% |
| Jun 30, 2023 | 11 | -3 | -21.43% |
| Mar 31, 2023 | 12 | -2 | -14.29% |
| Dec 31, 2022 | 13 | 1 | 8.33% |
| Sep 30, 2022 | 14 | 2 | 16.67% |
| Jun 30, 2022 | 14 | 3 | 27.27% |
| Mar 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 69 |
| Saniona AB | 44 |
| Genovis AB (publ.) | 42 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| SynAct Pharma AB | 8 |
| Flerie AB | 8 |
| Isofol Medical AB | 7 |
AlzeCure Pharma AB News
- 6 weeks ago - AlzeCure Pharma AB Transcript: Investor update - Transcripts
- 6 weeks ago - AlzeCure Pharma AB Press release: Investor update - Filings
- 6 weeks ago - AlzeCure Pharma AB Slides: Investor update - Filings
- 6 weeks ago - AlzeCure Pharma AB Slides: Investor presentation - Filings
- 2 months ago - AlzeCure Pharma AB Slides: Pareto Securities Capital Market Days presentation - Filings
- 2 months ago - AlzeCure Pharma AB Quarterly report: Q2 2026 - Filings
- 5 months ago - AlzeCure Pharma AB Transcript: Study update - Transcripts
- 5 months ago - AlzeCure Pharma AB Press release: Study update - Filings